Rethinking Anticoagulation for Left Atrial Appendage Closure

Vinay Guduguntla^{1

2}, Kristen K Patton^{3

4}

Affiliations

¹ Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Editorial Fellow, JAMA Cardiology.
³ Department of Medicine, Division of Cardiology, University of Washington School of Medicine, Seattle.
⁴ Associate Editor, JAMA Cardiology.

Comment

Vinay Guduguntla et al. JAMA Cardiol. 2024.

. 2024 Oct 1;9(10):927.

doi: 10.1001/jamacardio.2024.2390.

Vinay Guduguntla^{1

2}, Kristen K Patton^{3

4}

¹ Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Editorial Fellow, JAMA Cardiology.
³ Department of Medicine, Division of Cardiology, University of Washington School of Medicine, Seattle.
⁴ Associate Editor, JAMA Cardiology.

No abstract available

Comment on

Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial.
Freixa X, Cruz-González I, Cepas-Guillén P, Millán X, Antúnez-Muiños P, Flores-Umanzor E, Asmarats L, Regueiro A, López-Tejero S, Li CP, Sanchis L, Rodés-Cabau J, Arzamendi D. Freixa X, et al. JAMA Cardiol. 2024 Oct 1;9(10):922-926. doi: 10.1001/jamacardio.2024.2335. JAMA Cardiol. 2024. PMID: 39110427 Free PMC article. Clinical Trial.